Insights
April 14, 2026 USPTO Announces PIER Pilot Program That May Impact US National Phase Applications Marshall Gerstein Insights Jeremy R. Kriegel
March 4, 2026 "Building Strategic Partnerships Between IP Law Firms and Biopharma" Life Science Leader Eric M. Brusca, Ph.D.
February 26, 2026 Current Trends in Patent Law: Biotech/Life Sciences and AI/Computer Technologies Perspectives Association of Corporate Counsel’s (ACC) 2026 IP Palooza Joshua Elliott, Randall Rueth
February 16, 2026 – Podcast "Innovation: The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney" BioTalk Unzipped Katherine L. Neville, Ph.D.
November 3, 2025 "AI and the New IP Playbook for Biotech-Software Innovators" ACC Docket Cameron B. Pick
July 21, 2025 “Managing AI-based Medical and Life Science Technologies” AUTM 2025 Central Regional Meeting, Madison, Wisconsin Ryan N. Phelan
March 26, 2025 "Navigating AI’s Impact on Life Sciences and Patent Law" Life Science Leader Noah K. Tilton
December 9, 2024 – Podcast Kate Neville on The Biotech Startups Podcast The Biotech Startups Katherine L. Neville, Ph.D.
October 9, 2024 USPTO Will Terminate the AFCP 2.0 Program Marshall Gerstein Alert
September 4, 2024 "AI is a Tool — Not a Replacement — For Human Innovation in Drug Discovery" Drug Discovery Online Katherine L. Neville, Ph.D.
May 17, 2024 “How to Incentivize BioPharma R&D with a Culture of Innovation” PharmaSource Katherine Neville, Ph.D.
April 25, 2024 FTC Outlaws Noncompetes—What You Need to Know Marshall Gerstein Alert Thomas L. Duston
November 13, 2023 “Federal Circuit Imperils Term-Adjusted Patents” ALM’s IP Strategist Sandip H. Patel
Winter 2023 Edition “RNAi Technology Compatibility in the US and EU – Comparisons and Future Perspectives” UCLA Journal of Law & Technology, Vol. 28, No. 1 Izabella Higson
March 1, 2023 “The Complicated Intersection of Artificial Intelligence, Life Sciences and Intellectual Property" Life Science Leader Ryan Phelan
June 17, 2021 “How I Made Law Firm Leader: Advice From Marshall Gerstein Executive Committee Member Sandip Patel” Law.com
April 8, 2021 "Marshall Gerstein Got Creative to Stay Connected, Managing Partner Says" (featured quotes) The Mid-Market Report Jeffrey Sharp
September/October 2020 Issue "Does Section 285 Permit an Award of Attorney's Fees for Patent Office Proceedings?" IP Litigator Sandip Patel
August 20, 2020 Federal Circuit Grants Licensees More Control Over Infringement Litigation Marshall Gerstein Alert Robert Gerstein
August 19, 2020 A USPTO Examination Policy Change You May Have Missed Law360 David Gass
July 31, 2020 Effective October 2, 2020: Final Rule—Setting and Adjusting Patent Fees Marshall Gerstein Insights Jeremy Protas
July 13, 2020 "Patenting Considerations for 3D-Printed Medical Devices" 24x7 Magazine Meggan Duffy and Robert (Rob) Jacobson
February 4, 2020 "The PTAB Precedential Opinion Panel's Hulu Decision: Any Guidance is Better than No Guidance" IPWatchdog Sandip Patel
January 3, 2020 "What To Expect In Patent Litigation This Year" Law360 Mark Izraelewicz, John Labbé, and Thomas Burns
January 2020 Issue "IP Due Diligence Checklist: What To Address Before Executing A Transaction" Life Science Leader Eric M. Brusca, Ph.D.
June 17, 2019 State University Patents Are Not Immune from Inter Partes Review Marshall Gerstein Alert Julie M. Watson
April 15, 2019 "What Qualifies as Prior Art?" North Carolina Lawyers Weekly and South Carolina Lawyers Weekly Eric M. Brusca, Ph.D.
April 2, 2019 Japan Patent Office Relaxes Reduced-Fee Requirements Marshall Gerstein Alert Jeremy D. Protas
March 2019 issue "A Period of Adjustment" Intellectual Property Magazine Katherine L. Neville, Ph.D.
February 28, 2019 New EU Rules Will Help Generics and Biosimilars Marshall Gerstein Alert Michael Muczynski
January/February 2019 Issue "Supreme Court Decision Invites Confusion and Delay" IP Litigator Sandip H. Patel
January 25, 2019 "The Startup Drugmaker's Post-Helsinn Survival Guide" (featured quotes) Law360 Shelley Danek, Ph.D.
January 24, 2019 Supreme Court Confirms Secret Sales Can Invalidate Patents Marshall Gerstein Alert Sandip H. Patel
December 17, 2018 "The Biggest Patent Cases of 2018" (featured quotes) Law360 Sandip H. Patel
December 13, 2018 "Industry Reaction to Helsinn Healthcare v. Teva Pharmaceuticals Oral Arguments" (featured quotes) IPWatchdog Sandip H. Patel
December 12, 2018 Obviousness-Type Double Patenting Does Not Invalidate a Patent Term Extension Marshall Gerstein Alert
December 5, 2018 "Supreme Court Steps in as Grammar Police for AIA's On-Sale Bar" (featured quotes) BioWorld Sandip H. Patel
December 5, 2018 "US Supreme Court Likely to Limit On-Sale Bar to Public Prior Art" (featured quotes) Managing Intellectual Property Sandip H. Patel
December 5, 2018 "SCOTUS Helsinn v Teva Showdown Begins" (featured quotes) Intellectual Property Magazine Sandip H. Patel
December 4, 2018 "SCOTUS Likely to Reverse Helsinn v Teva Ruling, Say Lawyers" (featured quotes) World Intellectual Property Review Sandip H. Patel
June 21, 2018 USPTO Memo Addresses Federal Circuit Authority on Patent Eligibility of Some Treatment Methods Marshall Gerstein Alert William K. Merkel, Ph.D.
April 25, 2018 "Oil Firms' Supreme Court Spat Could Change Patent Law, Attorneys Say" (featured quotes) Westlaw Journal Intellectual Property Sandip H. Patel
April 25, 2018 "SAS: When the Patent Office Institutes IPR it Must Decide Patentability of All Challenged Claims" (featured quotes) IPWatchdog Sandip H. Patel
April 24, 2018 Supreme Court Decides that IPR Final Decisions Must Address All Challenged Claims Marshall Gerstein Alert Sandip Patel and Michael Weiner
April 24, 2018 The Supreme Court Finds IPR Proceedings Constitutional Marshall Gerstein Alert Thomas L. Duston and Julianne M. Hartzell
April 17, 2018 "SCOTUS: Patent Case Sparks Concerns Over International Relations" (featured quotes) World Intellectual Property Review Sandip H. Patel
April 16, 2018 "Justices Press Both Sides Over Foreign Patent Damages" (featured quotes) Law360 Sandip H. Patel
November/December 2017 Issue "Fractured Federal Circuit Reallocates a Burden of Proof in AIA Trials" IP Litigator Sandip Patel and Michael Weiner
December 4, 2017 – Presentation “Biosimilars: Get Ready, Get Set…” 2017 Consero IP Forum for Life Sciences John Labbé
October 22, 2017 – Presentation "Orientation and Speed Mentoring for New Members & First Time Attendees" LES Annual Meeting Pamela Cox
